相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overview of Myeloproliferative Neoplasms History, Pathogenesis, Diagnostic Criteria, and Complications
Douglas Tremblay et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
Rory M. Shallis et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Damien Luque Paz et al.
BLOOD ADVANCES (2020)
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
Vincenzo Accurso et al.
CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS (2020)
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study
Vincenzo Accurso et al.
HEMATOLOGY REPORTS (2019)
Mutation profiling by targeted sequencing of triple-negative essential thrombocythaemia patients
Mankai Ju et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
A Rare Case of Triple-Negative Essential Thrombocythemia in a Young Postsplenectomy Patient: A Diagnostic Challenge
T. Akcan et al.
CASE REPORTS IN HEMATOLOGY (2018)
Genomic profile of a patient with triple negative essential thrombocythemia, unresponsive to therapy: A case report and literature review
Uzma Zaidi et al.
JOURNAL OF ADVANCED RESEARCH (2017)
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients
Alessandro Andriani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo clinic patients
Mahnur Haider et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi et al.
BLOOD (2014)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
Robyn M. Emanuel et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs) - An international internet-based survey of 1179 MPD patients
Ruben A. Mesa et al.
CANCER (2007)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
